Open

Weston Family Foundation - Rapid Response Program

Q: How much funding can be received?

Weston Family Foundation - Rapid Response Program Funds up to $300,000 of admissible expenses.

Q: Who can I contact for more information about the Weston Family Foundation - Rapid Response Program?

You can contact The W. Garfield Weston Foundation (WFF).

Q: Where is the Weston Family Foundation - Rapid Response Program available?

The Weston Family Foundation - Rapid Response Program program is available across Canada.

Q: Is the Weston Family Foundation - Rapid Response Program a grant, loan, or tax credit?

Weston Family Foundation - Rapid Response Program is a Grant and Funding

Q: Who are the financial supporters of the Weston Family Foundation - Rapid Response Program?

Weston Family Foundation - Rapid Response Program is funded by The W. Garfield Weston Foundation (WFF)

Last Update: March 4, 2026

Canada

Supports high-impact research for neurodegenerative diseases of aging

Grant and Funding

The W. Garfield Weston Foundation

Overview

The initiative seeks to bridge the gap between scientific discovery and clinical application by supporting projects with preliminary data and high potential for impact. The program encourages collaboration among research institutions across Canada, fostering advancements that can significantly improve health outcomes for aging populations affected by neurodegenerative diseases.

At a glance

Funding available

Financing goals

Develop a new product

Research and experimental development

Conduct research

Eligible Funding

Maximum amount : 300,000 $

Timeline

Unspecified

Eligible candidates

Eligible Industries

All industries

Location

Canada

Legal structures

Non-profit

Annual revenue

All revenue ranges

Organisation size

All organization sizes

Audience

All groups

Non-profit candidates

Sector of operation

Research

Target groups

All the groups

Revenue structures

100% donations / grants

Scope

Provincial

Activities funded

Development of new therapeutics for neurodegenerative diseases.
Creation of tools such as biomarkers and drug delivery systems for aging-related conditions.

Examples of admissible projects:

$ 250,000

Development of a biomarker detection system for early diagnosis of neurodegenerative diseases

Eligibility

Who is eligible?

Research institutions in Canada with qualified donees.
Researchers working at least 50% of their time in Canada.

Eligible geographic areas

Canada

Selection criteria

Innovation and originality of the proposed research.
Feasibility supported by preliminary data.
Potential impact on neurodegenerative disease treatment or diagnostics.
Alignment with the program's objectives for high-risk, high-reward projects.

How to apply

Step 1: Prepare an expression of interest (LOI).Step 2: Submit the LOI by the specified deadline.Step 3: Await feedback and potential invitation to submit a full proposal.Step 4: Complete and submit the full application package.Step 5: Application review and decision notification.

Apply to this program

Frequently Asked Questions about the Weston Family Foundation - Rapid Response Program Program

Here are answers to the most common questions about the Weston Family Foundation - Rapid Response Program. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the Weston Family Foundation - Rapid Response Program?

The Weston Family Foundation’s Rapid Response Program provides vital seed funding to support high-impact, translational research focused on neurodegenerative diseases of aging. With a maximum of $300,000 available over 18 to 24 months, this program aims to catalyze innovative projects that can accelerate the development of therapeutics and diagnostic tools addressing unmet needs in neurodegenerative conditions. The initiative seeks to bridge the gap between scientific discovery and clinical application by supporting projects with preliminary data and high potential for impact. The program encourages collaboration among research institutions across Canada, fostering advancements that can significantly improve health outcomes for aging populations affected by neurodegenerative diseases.